The R22X Mutation of the SDHD Gene in Hereditary Paraganglioma Abolishes the Enzymatic Activity of Complex II in the Mitochondrial Respiratory Chain and Activates the Hypoxia Pathway
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Hereditary paragangliomas are usually benign tumors of the autonomic nervous system that are composed of cells derived from the primitive neural crest. Even though three genes (SDHD, SDHC, and SDHB), which encode three protein subunits of cytochrome b of complex II in the mitochondrial respiratory chain, have been identified, the molecular mechanisms leading to tumorigenesis are unknown. We studied a family in which the father and his eldest son had bilateral neck paragangliomas, whereas the second son had a left carotid-body paraganglioma and an ectopic mediastinal pheochromocytoma. A nonsense mutation (R22X) in the SDHD gene was found in these three affected subjects. Loss of heterozygosity was observed for the maternal chromosome 11q21-q25 within the tumor but not in peripheral leukocytes. Assessment of the activity of respiratory-chain enzymes showed a complete and selective loss of complex II enzymatic activity in the inherited pheochromocytoma, that was not detected in six sporadic pheochromocytomas. In situ hybridization and immunohistochemistry experiments showed a high level of expression of markers of the angiogenic pathway. Real-time quantitative reverse transcriptase (RT)-PCR measurements confirmed that vascular endothelial growth factor and endothelial PAS domain protein 1 mRNA levels were significantly higher (three- and sixfold, respectively) than those observed in three sporadic benign pheochromocytomas. Thus, inactivation of the SDHD gene in hereditary paraganglioma is associated with a complete loss of mitochondrial complex II activity and with a high expression of angiogenic factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These clinical observations and the finding of increased expression of HIF targets in tumors with SDH mutations [9,10] have suggested the possibility that the VHL and SDH syndromes intersect at the molecular level.”
From A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas (2005) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mitochondrial complex II is a component of the electron transport chain, and mutations of SDHB or SDHD genes that abrogate the oxidoreductase function of complex II can cause pheochromocytomas [9,14,15].”
From A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas (2005) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, patients harbouring mutations in SDH have increased HIF-1α activity23,24 and circulating succinate25.”
From Succinate is an inflammatory signal that induces IL-1β through HIF-1α (2013) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, mutations in subunit SdhB, SdhC, or SdhD are linked to tumorigenesis in the form of autosome-dominant familial paragangliomas and pheochromocytomas (1, 3, 16, 19, 33).”
From Loss of the SdhB, but Not the SdhA, Subunit of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation and Tumorigenesis (2008) · cites this paper as [19]
In the citing paper
“A relationship between SDH function and oxygen regulation has been suspected based on previous identification of increased expression of angiogenic factors in cases of SDH-mutant pheochromocytomas [9].”
From A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas (2005) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kinetic PCR Analysis: Real-time Monitoring of DNA Amplification Reactions
Higuchi, R., Fockler, C., Dollinger, G., & Watson, R. (1993) · Nature Biotechnology · doi:10.1038/nbt0993-1026 · Cited by 2,159 · cited 1×
“Relative quantitation of EPAS1 and VEGF gene expression was analyzed as a target-to-control expression ratio, using the standard curve method (Higuchi et al, 1993).”
MethodMitochondrial reactive oxygen species trigger hypoxia-induced transcription
Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E., Simon, M. C., & Schumacker, P. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11715 · Cited by 1,926 · cited 2×
“Mitochondria can act as O2 sensors by increasing the generation of reactive oxygen species, which are required for hypoxia-inducible factor 1 DNA–binding activity and subsequent increases in the synthesis of mRNA that encodes erythropoietin, vascular endothelial growth factor (VEGF), and glycolytic enzymes (Chandel et…”
BackgroundMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 6×
“The four exons of the SDHD gene (GenBank accession number AB 026906) were am- plified by PCR with primers and a procedure that has been described elsewhere (Baysal et al. 2000).”
BackgroundMethodInfluentialOxidative Phosphorylation at the fin de siècle
Saraste, M. (1999) · Science · doi:10.1126/science.283.5407.1488 · Cited by 1,313 · cited 2×
“Complex II or succinate-ubiquinone reductase (EC 1.3.99.1) is an important enzymatic complex crucial for both the tricarboxylic acid cycle and the aerobic respiratory chains of mitochondria (Saraste 1999).”
BackgroundInfluentialBiochemical and molecular investigations in respiratory chain deficiencies
Rustin, P., Chretien, D., Bourgeron, T., Gérard, B., Rötig, A., Saudubray, J. M., & Munnich, A. (1994) · Clinica Chimica Acta · doi:10.1016/0009-8981(94)90055-8 · Cited by 1,243 · cited 1×
“The activity of the respiratory-chain complexes was measured, as described elsewhere (Rustin et al. 1994).”
MethodSelf-citationAstuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087 · cited 2×
“Then, several germline SDHD mutations were reported in families with paraganglioma (Badenhop et al. 2001; Milunsky et al. 2001) and in families with pheochromocytoma (Astuti et al. 2001a).”
BackgroundMutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875 · cited 2×
“The SDHC gene encoding the large subunit of cytochrome b in succinate-ubiquinone oxidoreductase was reported to correspond to the PGL3 gene (Niemann and Müller 2000; Niemann et al. 2001).”
BackgroundDifferential Transcriptional Regulation of the Two Vascular Endothelial Growth Factor Receptor Genes
Gerber, H.-P., Condorelli, F., Park, J., & Ferrara, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23659 · Cited by 794 · cited 1×
“First, VEGF-R1 mRNA, which encodes the VEGF receptor induced in hypoxic conditions (Gerber et al. 1997), was found to be more abundant than VEGF-R2 mRNA.”
BackgroundBourgeron, T., Rustin, P., Chretien, D., Birch-Machin, M., Bourgeois, M., Viegas-Péquignot, E., Munnich, A., & Rötig, A. (1995) · Nature Genetics · doi:10.1038/ng1095-144 · Cited by 730 · cited 1×
“The causative mutation was identified in the SDHA gene encoding the flavoprotein of complex II, and the enzymatic defect was partial (Bourgeron et al. 1995).”
BackgroundSelf-citationNeurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells
SCHMECHEL, D., MARANGOS, P. J., & BRIGHTMAN, M. (1978) · Nature · doi:10.1038/276834a0 · Cited by 723 · cited 1×
“This result was expected, because NSE is considered an indicator of neuroendocrine differentiation (Schmechel et al. 1978).”
Background
Research works printed but not linked: 2
- Koreth, 1999, Chromosomes, 11q and cancer: a review, J Pathol, 187, 28, 10.1002/(SICI)1096-9896(199901)187:1<28::AID-PATH166>3.0.CO;2-R · doi:10.1002/(sici)1096-9896(199901)187:1<28::aid-path166>3.0.co;2-r
- Pacheco-Ojeda, 1988, Carotid body at high altitudes, World J Surg, 12, 856
Cited by
Items 301–364 of 364
Expression of mRNAs for Succinate Dehydrogenase Subunits and Related Genes in Pheochromocytoma
Isobe, K., Nissato, S., Tatsuno, I., YASHIRO, T., Takekoshi, K., & Kawakami, Y. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.027 · Cited by 2
Sánchez, F. S. L., Lozano, M. N., Gorjón, P. S., Medina, A., Herrera, Á. M. M., & González‐Sarmiento, R. (2010) · Angiología · doi:10.1016/s0003-3170(10)70051-1 · Cited by 2
SDHD mutations in carotid body tumors and pheochromocytomas: paraganglioma syndrome type 1
Bausch, B., Munk, R. D., Schipper, J. H., Hoegerle, S., Berger, D. P., Böhm, N., & Neumann, H. P. H. (2003) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200306000-00007 · Cited by 3
Genetic Diagnosis of Pheochromocytoma
Takekoshi, K., Isobe, K., & Kawakami, Y. (2008) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.97.2558 · Cited by 2
The Electron Transport Chain and Carcinogenesis
Brière, J.-J., Bénit, P., & Rustin, P. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-435-3_2 · Cited by 3
“vascularized and that this corresponded with hypoxia-inducible factor (HIF) stabilization and the activation of the hypoxia pathway [30].”
BackgroundSelf-citationApports de COMETE à la génétique du phéochromocytome
Gimenez‐Roqueplo, A., Burnichon, N., Amar, L., Favier, J., Jeunemaître, X., & Plouin, P. (2008) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32851-1 · Cited by 4
Self-citationPópulo, H., Batısta, R., Sampaio, C., Pardal, J., Lopes, J. M., & Soares, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180392 · Cited by 3
Paraganglioma and Pheochromocytoma
Iacobone, M., & Torresan, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-62241-1_15 · Cited by 2
Mitochondrial-to-Nuclear Communications in Cancer
Dakubo, G. D. (2010) · Springer eBooks · doi:10.1007/978-3-642-11416-8_4 · Cited by 2
Genetic Alterations in Pheochromocytoma and Paraganglioma
Welander, J. (2015) · Linköping University medical dissertations · doi:10.3384/diss.diva-114806 · Cited by 2
The Role Of Fumarase (FH) In Tumorigenesis
Lehtonen, R. (2006) · Helda - University of Helsinki Institutional Repository · Cited by 2
Paragangliome der Kopf-Hals-Region
Braun, S., Riemann, K., Pusch, C. M., Sotlar, K., Pfister, M., & Kupka, S. (2004) · HNO · doi:10.1007/s00106-003-0959-y · Cited by 2
Timmers, H. J. L. M., & Pacák, K. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.3.399 · Cited by 1
Prasad, C., Oakley, G. J., Yip, L., Coyne, C., Rangaswamy, B., & Dixit, S. B. (2014) · SAGE Open Medical Case Reports · doi:10.1177/2050313x14553520 · Cited by 1
Genetics of Pheochromocytoma and Paraganglioma
Babic, B., & Nilubol, N. (2016) · Springer eBooks · doi:10.1007/978-3-319-44136-8_5 · Cited by 1
Radionuclide Imaging of Pheochromocytoma and Paraganglioma in the Era of Multi-omics
Timmers, H. J. L. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-46038-3_12 · Cited by 1
Pheochromocytomas in Complex Genetic Disorders
Opocher, G., Ferrara, A. M., Zovato, S., Barbon, G., Taschin, E., & Schiavi, F. (2021) · Endocrinology · doi:10.1007/978-3-319-89497-3_14 · Cited by 1
DEFECTS IN TRICARBOXYLIC ACID CYCLE ENZYMES FUMARATE HYDRATASE AND SUCCINATE DEHYDROGENASE IN CANCER
Ylisaukko‐oja, S. K. (2007) · Helda - University of Helsinki Institutional Repository · Cited by 1
Pathogenesis of Pheochromocytoma
Isobe, K., Takekoshi, K., Kawakami, Y., & Nakai, T. (2003) · KARGER eBooks · doi:10.1159/000074655 · Cited by 1
The Pathogenesis of Pheochromocytomas: Of Mice and Men
Korpershoek, E. (2011) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 1
Zhou, S. X., Madden, B. J., Charlesworth, C. M., Hitosugi, T., Favier, J., & Maher, L. J., III (2026) · Journal of Biological Chemistry · doi:10.1101/2025.08.01.668168 · Cited by 4
Self-citationMutations de gènes impliqués dans le métabolisme énergétique et cancer
Thibault, C., & Gimenez‐Roqueplo, A. (2013) · ONCOLOGIE · doi:10.1007/s10269-013-2320-8
“L’ensemble de ces mutations semble avoir les mêmes conséquences fonctionnelles, à savoir la désintégration du complexe II mitochondrial et la perte de l’activité enzymatique SDH aboutissant à l’accumulation de succinate dans la mitochondrie et dans le cytosol [17,18,54].”
BackgroundSelf-citationMitochondrial Complex II in Cancer
Kľučková, K., Neužil, J., & Rohlena, J. (2014) · Springer eBooks · doi:10.1007/978-94-017-8984-4_4
Pediatric Paragangliomas: Role of Germline Mutation in Succinate Dehydrogenase
Prasad, P. K., & Yang, E. (2012) · Pediatric cancer · doi:10.1007/978-94-007-2957-5_30
Gimenez‐Roqueplo, A. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.4.2.143
Self-citationParagangliomas timpánicos y yugulares
Huy, P. T. B., & Duet, M. (2003) · EMC - Otorrinolaringología · doi:10.1016/s1632-3475(03)72002-5
The enzyme succinate dehydrogenase (SDH) and its role in hereditary pituitary adenomas
Панкратова, Ю. В., Przhiyalkovskaya, E. G., Pigarova, E. A., & Dzeranova, L. K. (2013) · Obesity and metabolism · doi:10.14341/omet2013410-15
Ronald, C. W., Lam, C., Chan, W., So, W., Tong, S., Chow, C., & Cockram, C. S. (2007)
Functional genomics of the Glanville fritillary butterfly
Kvist, J. (2014) · Helda - University of Helsinki Institutional Repository
Tan, T. Y., Goh, J. P. N., & Loke, S. C. (2013) · Springer eBooks · doi:10.1007/978-3-642-35579-0_20
Tests génétiques des syndromes des phéochromocytomes
Sokol, E. (2006) · Annales d Endocrinologie · doi:10.1016/s0003-4266(06)72559-8
Timmers, H. J. L. M., Gimenez‐Roqueplo, A., Mannelli, M., & Pacák, K. (2009)
Self-citationNeumann, H. P. H., Michelsen, K. S., & Yu, R. (2014)
Gastrointestinal Malignancy: Genetic Implications to Clinical Applications
Lopez, N., & Yeh, J. J. (2016) · Cancer treatment and research · doi:10.1007/978-3-319-34244-3_19
Hereditäre Paragangliome: Pathogenese und „Parent-of-Origin-Effekte“
Müller, U. (2010) · Medizinische Genetik · doi:10.1007/s11825-010-0240-1 · Cited by 1
Pheochromocytomas in Complex Genetic Disorders
Opocher, G., Ferrara, A. M., Zovato, S., Barbon, G., Taschin, E., & Schiavi, F. (2019) · Endocrinology · doi:10.1007/978-3-319-73082-0_14-1
Rouse, B. T. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717996838.793474112
Paraganglioma and Pheochromocytoma
Sandberg, A. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-510-7_5
Rôle de la succinate déshydrogénase dans le cancer
Moog, S., & Favier, J. (2022) · médecine/sciences · doi:10.1051/medsci/2022024 · Cited by 3
Self-citationGenomic Imprinting and Uniparental Disomy
Wang, J.-C. C. (2005) · Humana Press eBooks · doi:10.1385/1-59259-833-1:515
Zibari, G. B., Sanders, M., & Shokouh-Amiri, H. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1423-4_14
Blake, D. M., Tomovic, S., & Jyung, R. W. (2014) · Ear Nose & Throat Journal · doi:10.1177/0145561314093004-503
Metabolic mapping of high-fit and low-fit individuals for human physiological health
Janssen, J. J. E. (2022) · doi:10.18174/573397
Goncalves, J., Moog, S., Morin, A., Gentric, G., Müller, S., Morrell, A. P., Kľučková, K., Stewart, T. J., Andoniadou, C. L., Lussey‐Lepoutre, C., et al. (2023) · doi:10.1158/0008-5472.c.6513153.v1
Self-citationZhu, D., Zhang, J., Hashem, J., Gao, F., & Chen, C. (2023) · Figshare · doi:10.6084/m9.figshare.22615145
Sazhaev, E. A., Bugaeva, V. Y., Shchelkanova, E. S., & Терещенко, Г. В. (2023) · Radiology - Practice · doi:10.52560/2713-0118-2024-2-27-53
Wang, P., Gao, L., Zhang, W., Guo, R., & Xia, Y. (2025) · World Journal of Surgical Oncology · doi:10.1186/s12957-024-03641-w · Cited by 1
Imaging Lesions of the Skull Base
Goh, J. P. N., & Pulickal, G. G. (2025) · Medical radiology · doi:10.1007/174_2024_551
Succinate Dehydrogenase in Mitochondrial Disorders
Tripathi, S., Sharma, Y., & Kumar, D. (2025) · Springer eBooks · doi:10.1007/978-981-96-6831-1_5
Zhu, D., Zhang, J., Hashem, J., Gao, F., & Chen, C. (2023) · Figshare · doi:10.6084/m9.figshare.22615142
Zhu, D., Zhang, J., Hashem, J., Gao, F., & Chen, C. (2023) · Figshare · doi:10.6084/m9.figshare.22615124
Zhu, D., Zhang, J., Hashem, J., Gao, F., & Chen, C. (2023) · Figshare · doi:10.6084/m9.figshare.22615136
Zhu, D., Zhang, J., Hashem, J., Gao, F., & Chen, C. (2023) · Figshare · doi:10.6084/m9.figshare.22615130
Zhu, D., Zhang, J., Hashem, J., Gao, F., & Chen, C. (2023) · Figshare · doi:10.6084/m9.figshare.22615139
Zhu, D., Zhang, J., Hashem, J., Gao, F., & Chen, C. (2023) · Figshare · doi:10.6084/m9.figshare.22615133
Métabolisme oxydatif et mitochondrial des cellules cancéreuses de prostate
Matar, C. (2011) · theses.fr (ABES) · doi:10.70675/6abb943ez119bz424fzbe51z3467241fc235
Djohan, Y. F. (2017) · theses.fr (ABES) · doi:10.70675/d5731089zdcf9z4aefza338z8affdb118a6f · Cited by 1
Zhang, J., Tang, Z., Wang, Y., Wan, J., Zhou, Y., Li, J., & Ming, J. (2026) · Cells · doi:10.3390/cells15151422 · Cited by 3
Wu, J.-Y., Chang, T.-C., Chen, M.-J., Cho, S.-H., Liou, J., Kuo, C.-C., & Wu, K. K. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01289-0
“Those findings are in keeping with the reports that SDHB mutations in PG/PC as well as SDHB silencing with siRNA in cancer cells cause loss of SDH activity and succinate accumulation [10, 11, 19].”
Mutazioni germinali nel feocromocitoma non sindromico
Freiburg-Warsaw-Columbus Pheochromocytoma Study Group, Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B., Gimm, O., Frankc, G., Schipper, J. H., Klisch, J., Altehoefer, C., et al. (2003) · L Endocrinologo · doi:10.1007/bf03344445
Marini, A. (2014) · UnissResearch (Università degli Studi di Sassari)
Metadata
- Authors
- Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Mourad, J.-J., Plouin, P.-F., Corvol, P., Rötig, A., & Jeunemaitre, X.
- Affiliations
- Inserm (FR)
- Hôpital Saint-Michel (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2001-12
- Volume
- 69
- Issue
- 6
- Pages
- 1186-1197
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1235531
- OpenAlex
- W1975918337
- Cited by
- 364
- References
- 44
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 5 · 2023: 12 · 2022: 8 · 2021: 9 · 2020: 8 · 2019: 10 · 2018: 9 · 2017: 12 · 2016: 15 · 2015: 14 · 2014: 32 · 2013: 24 · 2012: 19
- FWCI
- 14.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4248 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- hereditary paraganglioma, succinate dehydrogenase, cytochrome b, mitochondrial respiratory chain, loss of heterozygosity, pheochromocytoma, carotid body paraganglioma, hypoxia pathway, angiogenic factors, vascular endothelial growth factor, EPAS1, tumor angiogenesis, SDHC, SDHB
- MeSH terms
- Adult, Aged, Amino Acid Sequence, Base Sequence, Chromosomes, Human, Pair 11, Consanguinity, Electron Transport, Female, Humans, Immunohistochemistry, Male, Middle Aged, Mitochondria, Oxygen, Paraganglioma, Pedigree, RNA, Messenger, Succinate Dehydrogenase, Cell Hypoxia, Gene Expression, In Situ Hybridization, Germ-Line Mutation, Codon, Nonsense, Loss of Heterozygosity, Reverse Transcriptase Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.